BioNTech, Scancell collaborate on T-cell receptors for cancer
BioNTech AG and Scancell Ltd. are collaborating on the development of T-cell receptor-based therapeutics for cancer using each other's respective technologies.
- Gene Therapy, Cell Therapy
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com